- TWD4.25bn
- TWD6.62bn
- TWD1.76bn
- 13
- 24
- 55
- 16
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,173 | 1,669 | 1,850 | 2,211 | 1,756 |
Cost of Revenue | |||||
Gross Profit | 948 | 749 | 783 | 1,004 | 716 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 2,017 | 1,647 | 1,775 | 2,079 | 1,769 |
Operating Profit | 156 | 21.1 | 75.3 | 131 | -13.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 135 | 31.1 | 74.6 | 86.5 | -31.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 107 | 63.5 | 89.3 | 91.8 | 6.53 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 106 | 62.4 | 87.4 | 91 | 6.21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 106 | 62.4 | 87.4 | 91 | 6.21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.81 | 1.03 | 1.44 | 1.53 | 0.102 |
Dividends per Share |